This Month in Psychopharmacology

THIS MONTH IN
PSYCHOPHARMACOLOGY

Early Intervention Service for Psychosis May Reduce Suicide in Patients with Schizophrenia
April 13, 2018

The suicide rate among patients with schizophrenia-spectrum disorders is significantly increased compared to the general population, especially during the first episode of psychosis...

Continue reading (Members only)

New York Is the First State To Require Mental Health Education in School
April 6, 2018

A new law going into effect July 1 will make New York the first state in the nation to require mental health education in grades kindergarten through 12...

Illinois Public Health Officials Warning About Synthetic Cannabinoid
April 3, 2018

Health officials in Illinois are warning people about synthetic cannabinoid products that are causing severe bleeding among users and, in some cases, death...

Pseudobulbar Affect Correlates with Mood Symptoms in Parkinsonian Disorders but not Amyotrophic Lateral Sclerosis
April 2, 2018

Pseudobulbar affect (PBA) is a psychiatric disorder characterized by inappropriate laughter and crying, independent of mood. PBA is common in amyotrophic lateral sclerosis (ALS) and is becoming...

Continue reading (Members only)

Mild Traumatic Brain Injury and Aggression, Impulsivity, and History of Other- and Self-Directed Aggression
March 30, 2018

Mild traumatic brain injury (mTBI) is highly prevalent in the United States, with an estimated 1.3 million reported annually. One of the major consequences of mTBI...

Continue reading (Members only)

FDA Approves Marketing of First Blood Test to Assist Evaluation of Concussion in Adults
March 27, 2018

On Feb 14, 2018, the US Food and Drug Administration (FDA) permitted marketing of the first blood test to evaluate mild traumatic brain injury (mTBI) in adults...

Continue reading (Members only)

Evidence for Neuroprogression in Untreated Depression: Microglial Activation
March 23, 2018

New brain imaging research from the Centre for Addiction and Mental Health (CAMH) shows that the brain alters after years of persistent depression...

Continue reading (Members only)

Autism Awareness: Review of Pharmacotherapy for Emotional/Behavioral Symptoms and Potential Future Targets
March 20, 2018

Autism spectrum disorder (ASD) is a neurodevelopmental disorder typically diagnosed in childhood and characterized by persistent deficits in social communication and interaction and restricted, repetitive patterns of behavior, interests, and activities. There are no pharmacological agents approved...

Serotonin Syndrome Is Rare With Concomitant Use of Triptans and Serotonergic Antidepressants
March 11, 2018

In this study, Orlova et al. set out to determine the validity of the 2006 FDA warning against increase risk of serotonin syndrome...

Continue reading (Members only)

FDA Approves Lurasidone for Pediatric Bipolar Depression
March 8, 2018

The US Food and Drug Administration (FDA) has approved lurasidone for the treatment of bipolar depression in pediatric patients (ages 10 to 17)...

Top of Page